Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Muro, Kei, Dr, Chung, Hyun Cheol, Prof, Shankaran, Veena, MD, Geva, Ravit, MD, Catenacci, Daniel, MD, Gupta, Shilpa, MD, Eder, Joseph Paul, MD, Golan, Talia, MD, Le, Dung T, MD, Burtness, Barbara, MD, McRee, Autumn J, MD, Lin, Chia-Chi, MD, Pathiraja, Kumudu, MA, Lunceford, Jared, PhD, Emancipator, Kenneth, MD, Juco, Jonathan, MD, Koshiji, Minori, MD, Bang, Yung-Jue, Prof
Published in The lancet oncology (01.06.2016)
Published in The lancet oncology (01.06.2016)
Get full text
Journal Article
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Fuchs, Charles S, Dr Prof, Tomasek, Jiri, MD, Yong, Cho Jae, Prof, Dumitru, Filip, MD, Passalacqua, Rodolfo, MD, Goswami, Chanchal, Prof, Safran, Howard, Prof, dos Santos, Lucas Vieira, MD, Aprile, Giuseppe, MD, Ferry, David R, Prof, Melichar, Bohuslav, Prof, Tehfe, Mustapha, MD, Topuzov, Eldar, Prof, Zalcberg, John Raymond, Prof, Chau, Ian, MD, Campbell, William, Prof, Sivanandan, Choondal, MD, Pikiel, Joanna, MD, Koshiji, Minori, MD, Hsu, Yanzhi, PhD, Liepa, Astra M, PharmD, Gao, Ling, PhD, Schwartz, Jonathan D, MD, Tabernero, Josep, MD
Published in The Lancet (British edition) (04.01.2014)
Published in The Lancet (British edition) (04.01.2014)
Get full text
Journal Article